A double-blind, placebo-controlled, randomized withdrawal trial of sarilumab for the treatment of glucocorticoid-dependent sarcoidosis.
Matthew C BakerAudra HoromanskiYiwen WangLiu YuhanShima ParsafarRobert FairchildJoshua J MooneyRishi RajRonald WittelesMark C GenovesePublished in: Rheumatology (Oxford, England) (2023)
ClinicalTrials.gov Identifier: NCT04008069.